| Impact of comorbidities on tumor necrosis factor inhibitor therapy in psoriatic arthritis: a population‐based cohort study C Ballegaard, P Højgaard, L Dreyer, R Cordtz, TS Jørgensen, ... Arthritis care & research 70 (4), 592-599, 2018 | 70 | 2018 |
| Peripapillary ovoid hyperreflectivity in optic disc edema and pseudopapilledema L Malmqvist, PA Sibony, CL Fraser, M Wegener, S Heegaard, ... Ophthalmology 125 (10), 1662-1664, 2018 | 40 | 2018 |
| Prevalence and histopathological signatures of optic disc drusen based on microscopy of 1713 enucleated eyes M Skougaard, S Heegaard, L Malmqvist, S Hamann Acta Ophthalmologica 98 (2), 195-200, 2020 | 38 | 2020 |
| Work disability in newly diagnosed patients with primary Sjögren syndrome T Mandl, TS Jørgensen, M Skougaard, P Olsson, LE Kristensen The Journal of Rheumatology 44 (2), 209-215, 2017 | 34 | 2017 |
| Relationship between fatigue and inflammation, disease duration, and chronic pain in psoriatic arthritis: an observational DANBIO registry study M Skougaard, TS Jørgensen, S Rifbjerg-Madsen, LC Coates, A Egeberg, ... The Journal of Rheumatology 47 (4), 548-552, 2020 | 31* | 2020 |
| The development of complex digital health solutions: formative evaluation combining different methodologies A Lee, M Sandvei, HC Asmussen, M Skougaard, J Macdonald, J Zavada, ... JMIR research protocols 7 (7), e9521, 2018 | 26 | 2018 |
| Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort study C Ballegaard, M Skougaard, J Guldberg-Møller, CV Nissen, K Amris, ... Rheumatology 60 (7), 3289-3300, 2021 | 25 | 2021 |
| Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients AE Secher, B Glintborg, H Gudbergsen, NS Krogh, IJ Sørensen, ... Scandinavian Journal of Rheumatology 48 (3), 178-184, 2019 | 16 | 2019 |
| Point of no return for improvement of cartilage quality indicated by dGEMRIC before and after weight loss in patients with knee osteoarthritis: a cohort study S Hangaard, H Gudbergsen, M Skougaard, H Bliddal, JD Nybing, ... Acta Radiologica 59 (3), 336-340, 2018 | 11 | 2018 |
| Increased prevalence of sleep disturbance in psoriatic arthritis is associated with inflammatory and non-inflammatory measures M Skougaard, ZR Stisen, TS Jørgensen, A Egeberg, RL Hansen, ... Scandinavian Journal of Rheumatology 52 (3), 259-267, 2023 | 8 | 2023 |
| Patients with rheumatoid arthritis acquire sustainable skills for home monitoring: a prospective dual-country cohort study (ELECTOR clinical trial I) M Skougaard, H Bliddal, R Christensen, K Ellegaard, SM Nielsen, ... The Journal of rheumatology 47 (5), 658-667, 2020 | 7 | 2020 |
| The parker model: applying a qualitative three-step approach to optimally utilize input from stakeholders when introducing new device technologies in the management of chronic … TS Jørgensen, M Skougaard, PC Taylor, HC Asmussen, A Lee, L Klokker, ... The Patient-Patient-Centered Outcomes Research 11, 515-526, 2018 | 7 | 2018 |
| Fatigue is a systemic extraintestinal disease manifestation largely independent of disease activity, chronicity, and nutritional deficiencies in inflammatory bowel disease on … KR Christensen, MA Ainsworth, C Steenholdt, S Buhl, M Skougaard, ... Scandinavian Journal of Gastroenterology 57 (9), 1051-1057, 2022 | 6 | 2022 |
| Trial Characteristics as Contextual Factors When Evaluating Targeted Therapies in Patients With Psoriatic Disease: A Meta‐Epidemiologic Study C Ballegaard, TS Jørgensen, M Skougaard, V Strand, PJ Mease, ... Arthritis care & research 70 (8), 1206-1217, 2018 | 6 | 2018 |
| Communication strategies are highly important to avoid nocebo effect when performing non-medical switch from originator product to biosimilar product: Danish results from … TS Jørgensen, M Skougaard, HC Asmussen, A Lee, PC Taylor, ... Arthritis & Rheumatology 69 (Suppl. 10), 2260, 2017 | 6 | 2017 |
| Communication strategies are highly important to avoid nocebo effect when performing non-medical switch from originator product to biosimilar product: Danish results from … TS Jørgensen, M Skougaard, HC Asmussen, A Lee, PC Taylor, ... Arthritis & Rheumatology 69 (Suppl. 10), 2260, 2017 | 6 | 2017 |
| Four emerging immune cellular blood phenotypes associated with disease duration and activity established in Psoriatic Arthritis M Skougaard, SB Ditlev, ZR Stisen, LC Coates, K Ellegaard, ... Arthritis Research & Therapy 24 (1), 262, 2022 | 5 | 2022 |
| Identifying and understanding disease burden in patients with inflammatory bowel disease KR Christensen, MA Ainsworth, M Skougaard, C Steenholdt, S Buhl, ... BMJ Open Gastroenterology 9 (1), e000994, 2022 | 5 | 2022 |
| Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort study M Skougaard, TS Jørgensen, MJ Jensen, C Ballegaard, ... Rheumatology advances in practice 5 (3), rkab076, 2021 | 5 | 2021 |
| Assessing the importance of trial characteristics as contextual factors when evaluating targeted therapies in patients with psoriatic disease: protocol for an exploratory … C Ballegaard, TS Jørgensen, M Skougaard, V Strand, PJ Mease, ... The Parker Institute, 2016 | 5 | 2016 |
